Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profound Medical | PROF | Sep 27, 2024 | 7.92 | +0.89 |
ProFrac A | ACDC | Sep 27, 2024 | 6.69 | +4.21 |
PROG | PRG | Sep 27, 2024 | 48.19 | -0.10 |
Progress Software | PRGS | Sep 27, 2024 | 66.30 | +0.70 |
Progressive | PGR | Sep 27, 2024 | 251.10 | -0.51 |
Progyny | PGNY | Sep 27, 2024 | 16.80 | +0.48 |
Project Energy Reimagined Acquisition Unit | PEGRU | Sep 27, 2024 | 11.10 | 0.00 |
ProKidney | PROK | Sep 27, 2024 | 1.86 | -8.82 |
Prologis | PLD | Sep 27, 2024 | 125.59 | +0.29 |
ProMIS Neurosciences | PMN | Sep 27, 2024 | 1.28 | -0.78 |
PropertyGuru | PGRU | Sep 27, 2024 | 6.63 | +0.30 |
ProPetro | PUMP | Sep 27, 2024 | 7.54 | +2.72 |
ProPhase Labs | PRPH | Sep 27, 2024 | 2.40 | +5.73 |
ProQR Therapeutics | PRQR | Sep 27, 2024 | 1.83 | +2.81 |
PROS | PRO | Sep 27, 2024 | 18.85 | -1.52 |
ProShares Bitcoin Strategy ETF | BITO | Sep 27, 2024 | 19.88 | +1.38 |
Proshares Ultra FTSE Europe | UPV | Sep 27, 2024 | 70.16 | -0.14 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Sep 27, 2024 | 54.84 | -11.55 |
Proshares Ultrashort FTSE Europe | EPV | Sep 27, 2024 | 6.63 | +0.15 |
Prospect Capital | PSEC | Sep 27, 2024 | 5.31 | +0.57 |
Prospect Capital A Pref | PSEC-A | Sep 27, 2024 | 19.31 | -2.96 |
Prosperity Bancshares | PB | Sep 27, 2024 | 70.80 | -0.85 |
Protagenic Therapeutics | PTIX | Sep 27, 2024 | 0.62 | +8.56 |
Protagonist Therapeutics | PTGX | Sep 27, 2024 | 44.56 | -0.82 |
Protalix Bio Therapeutics | PLX | Sep 27, 2024 | 1.05 | -1.87 |
Protara Therapeutics | TARA | Sep 27, 2024 | 1.89 | +3.28 |
Prothena | PRTA | Sep 27, 2024 | 20.05 | -0.45 |
Proto Labs | PRLB | Sep 27, 2024 | 29.42 | +1.17 |
Provident Bancorp | PVBC | Sep 27, 2024 | 10.69 | -0.28 |
Provident Financial | PROV | Sep 27, 2024 | 14.39 | +0.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.